Sanofi

This study aims to monitor the safety of a high-dose flu vaccine (Efluelda®) in adults aged 65 and older in South Korea. Researchers will track any side effects or reactions that occur in about 670 participants for approximately one month after they receive their routine flu shot…

This study aims to monitor the safety of a high-dose flu vaccine (Efluelda Tetra) in adults aged 65 and older in South Korea. It will track any side effects or reactions that occur in the month following vaccination under normal doctor's office conditions. The goal is to gather r…

This study aims to check the safety of the drug belumosudil in Indian patients aged 12 and older who have chronic graft-versus-host disease (cGVHD) after a stem cell transplant. Participants will take the drug for up to 24 weeks and be monitored for side effects. The study will a…

This study is testing if adding an injectable drug called sarilumab to a standard steroid treatment works better for controlling polymyalgia rheumatica (PMR) than the steroid treatment alone. It will involve 300 adults with early or recently flared PMR. Participants will receive …

This study is testing a new drug called itepekimab for Japanese adults with chronic sinusitis and nasal polyps that haven't been helped enough by previous surgery or steroid treatments. Over 52 weeks, researchers will see if the drug can safely shrink polyps and improve symptoms …

This study aims to learn about the long-term safety and effectiveness of an investigational drug called balinatunfib for adults with Crohn's disease or ulcerative colitis. It will follow about 325 people who have already completed a previous 1-year study with this medication. The…